The federal government should negotiate drug prices for Medicare and force drugmakers to explain how they set drug prices, according to a survey out Tuesday of people 50 and older by AARP, the nation’s largest organization of people this age.
The survey showed more than 93% of adults 50 and older said they favored the Medicare price negotiations, a policy advocated by presidential candidates Hillary Clinton, Bernie Sanders and Donald Trump. President Obama included such price negotiation authority for drugs known as biologics and "high-cost drugs" in his recent budget proposals .
Read Full Article »